warfarin
FDA Approved
Description
Warfarin is an oral anticoagulant that inhibits vitamin K-dependent clotting factors. It is used in Sneddon syndrome to prevent thrombotic events associated with the characteristic livedo reticularis and cerebrovascular manifestations. Long-term anticoagulation helps reduce stroke risk in these patients.
Indications & Therapeutic Use
thromboembolism prophylaxis, stroke prevention, Sneddon syndrome
Linked Diseases:
Sneddon syndrome
M30.8D018860
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
warfarin
| Generic Name | warfarin |
| Brands | 1 brand available |
| Active Ingredient | warfarin sodium |
| Drug Class | thromboembolism prophylaxis |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | Oral tablet, 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg, 6mg, 7.5mg, 10mg |
| Medical Code | B01AA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes